Publications by authors named "Mustafa İlker İnan"
Introduction: Primary immunodeficiency diseases (PIDs), are a growing group of rarely seen diseases. Various clinical conditions like autoimmunity, lymphoproliferative/malignant diseases, chronic lung and gastrointestinal system diseases have been identified which accompanies PIDs besides recurrent infections. However, there is a lack of information about accompanying cardiovascular diseases.
View Article and Find Full Text PDFArticle Synopsis
- Chronic spontaneous urticaria (CSU) negatively impacts patients' quality of life, and omalizumab is recommended for cases resistant to antihistamines; the Urticaria Activity Score-7 (UAS-7) measures disease severity.* -
- A study compared the long-term effectiveness and side effects of two doses (150 mg and 300 mg) of omalizumab in 108 CSU patients over 60 months, finding no significant differences in disease scores or adverse events between groups.* -
- The research concluded that starting with a 150 mg dose is adequate for CSU treatment, with an option to increase to 300 mg if needed, offering a potentially safer and more
Introduction: Anaphylaxis is a severe and life-threatening systemic hypersensitivity reaction. The most frequently encountered causes are foods, drugs, and bee venom, but anaphylaxis may also occur idiopathically. Paradoxical vocal cord movement (PVCM), is a cause of upper airway obstruction due to abnormal adduction of vocal cords during inspiration and, to some degree on expiration.
View Article and Find Full Text PDFIntroduction: Cytarabine (ARA-C) is an antimetabolite agent used especially in the treatment of hematologic malignancies. Infusion reactions have an important place among the side effects that may occur due to treatment. Clinical findings of infusion reactions resemble allergic reactions.
View Article and Find Full Text PDF